Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cardona

Showing results (231-240 of 333) with videos related to

Pageof 34
Sort By:
Frontiers in Oncology|February 18, 2025
Case report: Chest radiotherapy-induced vertebral fractures in lung cancer patients: a case series and literature reviewOscar Arrieta, Francisco Lozano-Ruiz, Alberto Guijosa, et al.
Pharmaceutics|June 24, 2022
Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old QuestionCamila Ordóñez-Reyes, Juan Esteban Garcia-Robledo, Diego F Chamorro, et al.
Frontiers in Oncology|December 19, 2023
PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesotheliomaAlejandro Avilés-Salas, Luis Cabrera-Miranda, Norma Hernández-Pedro, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 12, 2023
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLCLuis Lara-Mejía, Andres F Cardona, Luis Mas, et al.
BMC Cancer|August 6, 2021
RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatinWendy Muñoz-Montaño, Sae Muñiz-Hernández, Alejandro Avilés-Salas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2025
Corrigendum to 'Impact of concurrent genomic alterations on clinical outcomes in patients with ALK-rearranged non-small cell lung cancer' [Journal of Thoracic Oncology, Volume 19 Issue 1 (2024) 119-129]Luis Lara-Mejía, Andres F Cardona, Luis Mas, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 15, 2024
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLCDiego de Miguel-Perez, Murat Ak, Priyadarshini Mamindla, et al.
The Oncologist|April 1, 2024
Early Incorporation to Palliative Care (EPC) in Patients With Advanced Non-Small Cell Lung Cancer: The PACO Randomized Clinical TrialSilvia Allende, Jenny G Turcott, Emma Verástegui, et al.
Revista De Gastroenterologia De Mexico|June 8, 2012
[Morbidity and mortality in a series of patients suffering from intraperitoneal neoplasia treated with peritoneal cytoreduction and hyperthermic intraperitoneal chemotherapy at the Fundación Santa Fe de Bogotá Teaching Hospital (ONCOLGroup--ATIA study)]F Arias, J M Otero, E Londoño, et al.
Biomarker Research|November 16, 2023
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancerDiego de Miguel-Perez, Francisco Gabriel Ortega, Rosario Guerrero Tejada, et al.
Pageof 34

Showing results (231-240 of 333) with videos related to

Sort By:
Pageof 34
Frontiers in Oncology|February 18, 2025
Case report: Chest radiotherapy-induced vertebral fractures in lung cancer patients: a case series and literature reviewOscar Arrieta, Francisco Lozano-Ruiz, Alberto Guijosa, et al.
Pharmaceutics|June 24, 2022
Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old QuestionCamila Ordóñez-Reyes, Juan Esteban Garcia-Robledo, Diego F Chamorro, et al.
Frontiers in Oncology|December 19, 2023
PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesotheliomaAlejandro Avilés-Salas, Luis Cabrera-Miranda, Norma Hernández-Pedro, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 12, 2023
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLCLuis Lara-Mejía, Andres F Cardona, Luis Mas, et al.
BMC Cancer|August 6, 2021
RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatinWendy Muñoz-Montaño, Sae Muñiz-Hernández, Alejandro Avilés-Salas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2025
Corrigendum to 'Impact of concurrent genomic alterations on clinical outcomes in patients with ALK-rearranged non-small cell lung cancer' [Journal of Thoracic Oncology, Volume 19 Issue 1 (2024) 119-129]Luis Lara-Mejía, Andres F Cardona, Luis Mas, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 15, 2024
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLCDiego de Miguel-Perez, Murat Ak, Priyadarshini Mamindla, et al.
The Oncologist|April 1, 2024
Early Incorporation to Palliative Care (EPC) in Patients With Advanced Non-Small Cell Lung Cancer: The PACO Randomized Clinical TrialSilvia Allende, Jenny G Turcott, Emma Verástegui, et al.
Revista De Gastroenterologia De Mexico|June 8, 2012
[Morbidity and mortality in a series of patients suffering from intraperitoneal neoplasia treated with peritoneal cytoreduction and hyperthermic intraperitoneal chemotherapy at the Fundación Santa Fe de Bogotá Teaching Hospital (ONCOLGroup--ATIA study)]F Arias, J M Otero, E Londoño, et al.
Biomarker Research|November 16, 2023
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancerDiego de Miguel-Perez, Francisco Gabriel Ortega, Rosario Guerrero Tejada, et al.
Pageof 34